The investigators want to establish a new model of acute febrile disease by mimicking the conditions seen in hospitalized patients in regards to inflammation, immobilisation and fasting. In this new model of disease, healthy young adults will be given lipopolysaccharide (LPS) to induce endotoxemia and inflammation/fever and then fast and bedrest for 36 hours. Glucose, fat and protein metabolism will be investigated using clamp technique and tracer methodology together with intracellular signalling pathway activation in muscle and fat biopsies. This new model of disease will later be used in another study to investigate different protein supplement´s effect on muscle waste during acute febrile disease.
The investigators want to establish a new model of acute febrile disease by mimicking the conditions seen in hospitalized patients in regards to inflammation, immobilisation and fasting. In this new model of disease, healthy young adults will be given lipopolysaccharide (LPS) to induce endotoxemia and inflammation on study day 1 and then fast and bedrest for 36 hours (Study day 2). Glucose, fat and protein metabolism will be investigated using clamp technique and tracer methodology together with intracellular signalling pathway activation in muscle and fat biopsies. This new model of disease will later be used in another study to investigate different protein supplement´s effect on muscle waste during acute febrile disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
6
LPS endotoxin is administered on study day 1 and immobilization and fast continue throughout study day 1 and 2.
Institute for Clinical MEdicine
Aarhus, Denmark
insulin sensitivity
Measured by hyperinsulinemic euglycemic clamp technique
Time frame: After a 3 hour clamp
Protein metabolism
Quantified by phenylalanine and tyrosine tracer methodology (whole body and the forearm model)
Time frame: measured at baseline and after 3 hours of clamp
ketone body metabolic changes
measurement of ketone bodies
Time frame: measured at baseline and after 3 hours of clamp
inflammation
Quantified by C-reactive peptide (CRP), white blood cell count, cytokines
Time frame: measurements over 36 hours
Intracellular signalling pathway activation
Intracellular signalling pathway activation in muscle and fat
Time frame: measured at baseline and after 3 hours of clamp
Energy expenditure
measured by indirect calorimetry
Time frame: measured at baseline and after 3 hours of clamp for 15 minutes
Glucose metabolism
measured by glucose tracer, calculations of rate of appearance, disappearance and endogenous glucose production
Time frame: measured at baseline and after 3 hours of clamp
Hormonal changes
measures of insulin, glucagon, c-peptide and growth hormone
Time frame: measured at baseline and after 3 hours of clamp
CD163
measures of CD163 and soluble CD163 (sCD163) after LPS exposure
Time frame: 0, 24 and 48 hours after LPS exposure
Fat metabolism
measured by palmitate tracer, calculating whole body palmitate flux. Measures of free fatty acids.
Time frame: measured at baseline and after 3 hours of clamp
Urea balance
measured by urea tracer and urine nitrogen excretion.
Time frame: measured at baseline and after 3 hours of clamp
Glucose uptake by the forearm
Arterio-venous balance x blodflow
Time frame: measured at baseline and after 3 hours of clamp
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.